Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 455-600-9 | CAS number: 790240-84-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 29.4 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: ECHA REACH guidance & ECETOC
- Overall assessment factor (AF):
- 60
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 1 763 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- As there is no inhalation study available an extrapolation using default assessment factors was performed. There was no information indicating other methods as more suitable.
- AF for dose response relationship:
- 1
- Justification:
- default, no information indicating otherwise is available
- AF for differences in duration of exposure:
- 6
- Justification:
- extrapolating subacute study to chronic study
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- not used for inhalation, ECHA Practical Guide 14, 2012
- AF for other interspecies differences:
- 1
- Justification:
- default, no information indicating otherwise is available
- AF for intraspecies differences:
- 5
- Justification:
- AF modified from Ecetoc TG 110 and German AGS 2006
- AF for the quality of the whole database:
- 1
- Justification:
- default, no information indicating otherwise is available
- AF for remaining uncertainties:
- 2
- Justification:
- ECHA Guidance, route to route extrapolation (oral to inhalation), conservative assumption
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 13.9
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: ECETOC technical report 110
- Overall assessment factor (AF):
- 72
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- As worst case scenario it was assumed that the dermal bioavailability is equal to the oral bioavailability (i.e. 100%)
- AF for dose response relationship:
- 1
- Justification:
- not required, starting point is NOAEL
- AF for differences in duration of exposure:
- 6
- Justification:
- extrapolating subacute study to chronic study
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- adjusting metabolic rates rat to human
- AF for other interspecies differences:
- 1
- Justification:
- not required according to ECETOC technical report 110
- AF for intraspecies differences:
- 3
- Justification:
- according to ECETOC technical report 110
- AF for the quality of the whole database:
- 1
- Justification:
- not required
- AF for remaining uncertainties:
- 1
- Justification:
- not required
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
The CSR characterizes the hazards and risks associated with the manufacturing and formulation of the registration substance. The only use of the substance is the manufacture of dyed paper.
The following section summarizes DNEL values derived for workers for which the main route of exposure would be dermal. Although less likely to occur, inhalation exposure is also considered. In a conservative approach, long-term systemic DNEL were calculated. As the substance is a dye and coloration during handling cannot be excluded, appropriate protection measures are in place to avoid exposure to high doses.
The most relevant study for DNEL derivation is the oral subacute study on the registration substance. Therefore, route-route extrapolation had to be applied for deriving certain DNELs. Derivation of inhalation DNEL is based on subacute oral study results. Derivation of assessment factors are based on ECETOC Technical Report 110 and ECHA Reach guidance. Modification was used according to German AGS 2010.
Systemic DNELs:
DNEL long-term systemic effects, inhalation:
The relevant dose descriptor selected to derive the inhalation DNEL was the subacute oral rat NOAEL of 1000 mg/kg bw/day. This dose descriptor, which is the starting point, was corrected for route-to-route extrapolation in accordance with the procedure recommended in Chapter R8 of the REACH Technical Guidance documents (May 2008) as follows:
NOAEL oral rat (NOAELoral rat) = 1000 mg/kg bw/day
Standard respiratory volume of a rat during 8 h exposure (SRvrat) =0.38 m3
Standard respiratory volume of a human during 8 h exposure (SRvhuman) = 6.7 m3/8hr
Standard respiratory volume of a human during light activity for a worker -8 h (WSRvhuman) =10 m3/8hr - light activity
NOECcorrfor workers = NOAELoral rat÷ SRvratx (SRvhuman÷ WSRvhuman)
Corrected NOEC = 1000 mg/kg bw/day ÷ 0.38 m3/kg bw x (6.7 m3÷ 10 m3)
Corrected NOEC =1763 mg/m3
According to the ECHA REACH Guidance as presented in Section R.8.4.3 of REACH guidance document R.8, Table R. 8-6 and ECETOC (2010)., the DNEL was then obtained by applying assessment factors to the starting point:
-Dose response relationship: An assessment factor of1is considered. There is no reason to consider special concern, because the starting point for the DNEL calculation is a NOAEL.
-Differences in duration of exposure: A default assessment factor of 6 was applied based on the extrapolation from subacute to chronic.
-interspecies differences (allometric scaling): No allometric scaling is considered in the derivation of the inhalation DNEL (ECHA Practical Guide 14, 2012). Differences in the allometry are assumed to be compensated by differences in the respiration rate.
-intraspecies differences: Taking into account the overall toxicity profile of the submission substance and the read across approach, a somewhat more conservative approach is taken and a combined inter-/intraspecies assessment factor of5is considered. This is in line with a similar concept developed by the German Committee for Hazardous Substances (AGS 2010).
-Remaining uncertainties: According to ECHA Guidance document, an assessment factor of 2 is considered for route to route extrapolation (oral to inhalation) as a conservative assumption.
Since the available data are adequate for labelling and classification purposes of the submission substance, the quality of the data base is judged sufficient for evaluation. Thus, an assessment factor of 1is applied.
The resulting overall Assessment Factor is 60 (1x 6 x 5 x 2 x1) resulting in a DNEL" long-term inhalation exposure – systemic effects” of 29.4 mg/m3/day.
Acute short-term systemic effects inhalation:
Due to the physico-chemical characteristics of the registration substance and the low vapor pressure, inhalation is not an exposure route of significant concern. The long term systemic inhalation DNEL is considered to be sufficient to ensure that no effects occur. Further, the existing technical and personal risk management measures in place are considered adequate and sufficient to ensure safe use of the substance.
DNEL long-term systemic effects, dermal:
A dermal systemic DNEL was derived from the oral subacute study, which revealed a NOAEL of 1000 mg/kg bw/d which is used as stating point. According to the ECHA REACH Guidance as presented in Section R.8.4.3 of REACH guidance document R.8, Table R. 8-6 and ECETOC (2010)., the DNEL was then obtained by applying assessment factors to the starting point:
-Differences in duration of exposure: A default assessment factor of 6 was applied based on the extrapolation from subacute to chronic.
-interspecies differences (allometric scaling): An allometric sca ling factor of 4 as default is used (ECHA Guidance, ECETOC 2010) (correction for differences in metabolic rate: rat to humans).
-intraspecies differences: According to ECETOC technical Report 110 an assessment Factor of 3 is considered.
-Dose response relationship: As no conspicuous behavior is observed an AF of 1 is taken.
Since the available data are adequate for labelling and classification purposes of the submission substance, the quality of the data base is judged sufficient for evaluation. Thus the assessment factor of 1 is applied.
The resulting overall Assessment Factor is 72 (6 x 4 x 3 x 1 x 1), resulting in a DNEL "long-term dermal exposure - systemic effects" of 13.9 mg/m2/day.
Short-term systemic effects, dermal DNELis not considered applicable. The long-term systemic dermal DNEL is considered to be sufficient to ensure that no effects occur. The registration substance is not dermal acute toxic, not irritant to the skin and not a skin sensitizer. The existing risk management measures in place are considered adequate and sufficient to ensure safe use of the substance.
Local DNELs
No DNEL for inhalation local effectswas established. The long term systemic inhalation DNEL is considered to be sufficient to ensure that no effects occur. The existing technical and personal risk management measures in place are considered adequate and sufficient to ensure safe use of the substance.
No DNEL long-term dermal for local effects was calculated for the registration substance. The long term systemic dermal DNEL is considered to be sufficient to ensure that no effects occur. The substance is not to be classified as irritating to the eye or irritating to skin, nor is the registration substance a sensitizer. Therefore, in this respect no DNEL derivation for long-term local effects is necessary.
No DNEL short-term dermal for local effects was calculated for the registration substance. The substance is not to be classified as irritating to the eye or irritating to skin, nor is the registration substance a sensitizer. Therefore, in this respect no DNEL derivation for long-term local effects is necessary.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 8.3 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: Assessment factors based on ECETOC Technical Report No. 110
- Overall assessment factor (AF):
- 120
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- not required
- AF for dose response relationship:
- 1
- Justification:
- not required
- AF for differences in duration of exposure:
- 6
- Justification:
- extrapolating subacute study to chronic study
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- adjusting metbolic rates rat to human
- AF for other interspecies differences:
- 1
- Justification:
- not required based on ECETOC Technical Report No. 110
- AF for intraspecies differences:
- 5
- Justification:
- based on ECETOC Technical Report No. 110
- AF for the quality of the whole database:
- 1
- Justification:
- not required
- AF for remaining uncertainties:
- 1
- Justification:
- not required
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 25 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: Assessment factors based on ECETOC Technical Report No. 110
- Overall assessment factor (AF):
- 40
- DNEL extrapolated from long term DNEL
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
General comment to DNEL derivation:
The substance registered is used as paper dye at paper manufacturing sites, and based on available information after the paper dyeing process the dye molecules are fixed to the paper fibres. It will not be bioavailable. Exposure of the general population to the dye is anticipated negligible. Based on this the general population is not getting in contact with the material in relevant amounts. Still the oral long-term DNEL was being derived for covering a theoretically possible exposure of the population with the substance. Derivation of inhalation and dermal DNELs are not applicable based on exposure grounds. There is no use resulting in direct exposure of the general population.
The most relevant study for DNEL derivation is the oral subacute study. Derivation of assessment factors are based on ECETOC Technical Report 110.
Systemic DNELs:
No DNELs for inhalation- or dermal exposure to the registration substance are established as there is no use resulting in direct exposure of the general population. Long-term and acute oral systemic DNELs were derived from the oral subacute study, which revealed a NOAEL of 1000 mg/kg bw/d.
Long-term oral systemic effects: A DNEL was derived from the oral subacute study, which revealed a NOAEL of 1000 mg/kg bw/d and is used as starting point. According to the ECHA REACH Guidance, the DNEL was then obtained by applying assessment factors to the starting point.
-Differences in duration of exposure: A default assessment factor of 6 was applied based on the extrapolation from subacute to chronic.
-interspecies differences (allometric scaling): An allometric scaling factor of 4 as default is used (ECHA Guidance, ECETOC 2010) (correction for differences in metabolic rate: rat to humans).
-intraspecies differences: According to ECETOC technical Report 110 an assessment Factor of 5 is considered.
-Dose response relationship: As no conspicuous behavior is observed an AF of 1 is taken.
Since the available data are adequate for labelling and classification purposes of the submission substance, the quality of the data base is judged sufficient for evaluation. Thus, an assessment factor of 1 is applied.
The resulting overall Assessment Factor is 120 (6 x 4 x 5 x 1 x 1), resulting in a DNEL "long-term oral exposure - systemic effects" of 8.3 mg/kg/day.
The short-term systemic dermal: DNEL is not considered applicable, as the registration substance is considered to be fixed to the paper fibres of paper articles and thus resulting in no direct exposure to the general population.
The short-term systemic oral: Based on ECHA's " Guidance on information requirements and chemical safety assessment - Chapter R.8: Characterisation of dose [concentration]-response for human health" the (oral) acute DNEL for systemic effects can by default be set as 1-5 times the long-term DNEL derived from the (oral) long-term exposure DNEL for systemic effects. Further guidance is provided by ECETOC Technical Report 110. Thus, the DNEL is calculated by multiplying the long term systemic oral DNEL of 8.3 mg/kg bw/day with a factor of 3, which leads to an oral short-term exposure DNEL for systemic effects of 25 mg/kg bw/day.
Local DNELs:
Long-term dermal DNEL for local effects:
No long-term local exposure to the registration substance is anticipated for the general population, i. e. based on the paper dying process the molecules are fixed to the paper fibres. Thus the general population is not getting in direct contact with the registration substance, and no DNEL for long-term dermal local effect is derived.
Short-term dermal DNEL for local effects
No DNEL for short-term dermal local effects has been quantified. As the substance registered is used for the manufacturing of paper, the general population is not involved in such a direct exposure scenario and thus resulting in no hazard for the skin or the eyes of the general population.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.